SCHEMBL6677564

SCHEMBL6677564

CC(C)(C)OC(=O)N(Cc1cc(N(S)C(N)=O)ccc1NCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
HDAC8 Q9BY41 3/20 0.34
AKT1 P31749 2/20 0.34
HDAC1 Q13547 3/20 0.34
HDAC3 O15379 1/20 0.34
HDAC2 Q92769 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
CD38 P28907 1/20 0.34
HDAC6 Q9UBN7 2/20 0.33
CDC7 O00311 1/20 0.33
ROCK2 O75116 1/20 0.33
MAP4K4 O95819 1/20 0.33
GSK3B P49841 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
RPS6KB1 P23443 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6676366 0.86 GRM2 (0.33) GRM2
SCHEMBL6676388 0.84 GRM2 (0.34) GRM2
SCHEMBL6680008 0.83 CA12 (0.39) CA12CA1CA7CA14HDAC8
SCHEMBL6681847 0.81 HDAC1 (0.33) CA12CA1CA7CA14HDAC8
SCHEMBL6678485 0.81 GRM2 (0.35) GRM2
SCHEMBL6675700 0.81 GRM2 (0.35) HDAC1HDAC3HDAC2NCOR2GRM2
SCHEMBL6676237 0.80 KEAP1 (0.36) AKT1HDAC1HDAC3HDAC2NCOR2
SCHEMBL6677559 0.80 AURKA (0.37) CA12CA1CA7CA14HDAC8
SCHEMBL6681810 0.80 GRM2 (0.39) GRM2
SCHEMBL6678438 0.80 GRM2 (0.35) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed